NCT04888975View on ClinicalTrials.gov

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery

NAUnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
LymphedemaLymphedema, Breast CancerLymphedema Arm
Interventions
DEVICE

Dayspring Active Wearable Compression System

Dayspring Active Wearable Compression System

Trial Locations (1)

94304

RECRUITING

Dung Nguyen, MD, PharmD, Palo Alto

Sponsors

Lead Sponsor

Koya Medical, Inc.
All Listed Sponsors
lead

Koya Medical, Inc.

INDUSTRY